Traws Pharma, Inc. - TRAW

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$3.855M
QoQ value delta ($000)
+$1.448M (+60.16%)
Implied price effect (QoQ)
-38.88%
Shares
Total shares
3,418,593
QoQ shares delta
+2,113,998 (+162.04%)
Total shares held by funds (by quarter)

Market chart (TRAW)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 34 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
ADAGE CAPITAL PARTNERS GP, L.L.C. 824 730,000 0.0%
Squadron Capital Management LLC 806 713,540 0.34%
Ikarian Capital, LLC 766 678,142 0.06%
ORBIMED ADVISORS LLC 684 605,531 0.01%
BOOTHBAY FUND MANAGEMENT, LLC 219 194,536 0.0%
ADAR1 Capital Management, LLC 174 154,431 0.01%
VANGUARD GROUP INC 98 87,259 0.0%
GEODE CAPITAL MANAGEMENT, LLC 69 61,653 0.0%
Seven Fleet Capital Management LP 55 49,260 0.04%
XTX Topco Ltd 47 42,210 0.0%
STATE STREET CORP 29 25,802 0.0%
CITADEL ADVISORS LLC 28 24,819 0.0%
TWO SIGMA INVESTMENTS, LP 21 19,244 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 16 14,197 0.0%
BlackRock, Inc. 11 9,956 0.0%
UBS Group AG 8 7,722 0.0%
BANK OF AMERICA CORP /DE/ 0 113 0.0%
FMR LLC 0 2 0.0%
CITIGROUP INC 0 1 0.0%
OSAIC HOLDINGS, INC. 0 8 0.0%
SBI Securities Co., Ltd. 0 162 0.0%
Robinswood Financial LLC 0 5 0.0%